KP Tissue (KPT.TO) Stock Price

KP Tissue Price

TSX·CLOSED
12.86CAD+0.05 (+0.39 %)
Market closed

Earnings per share have grown at 61.2% per year over the last 4 years. KP Tissue's net margin stands at 167.4%, up from -16.5% several years earlier. KP Tissue currently offers a dividend yield of about 5.60%. The payout ratio is around 85% of earnings. Analysts set a median price target of 11.22 CAD, implying 12.8% below the current price. Of 10 analysts, 0 rate the stock a buy — an overall Hold consensus. Over the past year KP Tissue shares have gained 36.4%. The stock trades about 41% above its 52-week low.

KP Tissue stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of KP Tissue over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how KP Tissue stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing KP Tissue's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

KP Tissue Stock Price History
DateKP Tissue Price
8/5/202612.86 CAD
8/4/202612.81 CAD
7/31/202612.94 CAD
7/30/202612.92 CAD
7/29/202612.79 CAD
7/27/202612.96 CAD
7/23/202612.80 CAD
7/22/202612.89 CAD
7/21/202612.82 CAD
7/20/202612.83 CAD
7/17/202612.97 CAD
7/16/202613.16 CAD
7/15/202613.04 CAD
7/14/202613.07 CAD
7/13/202612.98 CAD
7/10/202613.06 CAD
7/9/202613.20 CAD
7/8/202613.02 CAD
7/7/202613.14 CAD
7/6/202613.14 CAD
7/3/202612.93 CAD
7/2/202612.80 CAD
6/30/202613.22 CAD
6/29/202613.61 CAD
6/26/202613.60 CAD
6/25/202613.60 CAD
6/24/202613.36 CAD
6/23/202613.52 CAD
6/22/202613.31 CAD
6/19/202613.25 CAD
6/18/202613.17 CAD
6/17/202613.23 CAD
6/16/202613.28 CAD
6/15/202613.14 CAD
6/12/202613.08 CAD
6/11/202613.02 CAD
6/10/202612.86 CAD
6/9/202613.04 CAD
6/8/202612.89 CAD
6/5/202613.07 CAD
6/4/202612.90 CAD
6/3/202612.48 CAD
6/2/202612.46 CAD
6/1/202612.29 CAD
5/29/202612.19 CAD
5/28/202612.19 CAD
5/27/202612.04 CAD
5/26/202611.79 CAD
5/25/202611.85 CAD
5/22/202611.75 CAD
5/21/202611.73 CAD
5/20/202611.69 CAD
5/19/202611.77 CAD
5/15/202611.64 CAD
5/14/202611.59 CAD
5/13/202611.50 CAD
5/12/202611.48 CAD
5/11/202611.40 CAD
5/8/202611.41 CAD
5/7/202611.32 CAD
5/6/202611.35 CAD
5/5/202611.33 CAD
5/4/202611.38 CAD
5/1/202611.35 CAD
4/30/202611.38 CAD
4/29/202611.40 CAD
4/28/202611.22 CAD
4/27/202611.40 CAD
4/24/202611.20 CAD
4/23/202611.14 CAD
4/22/202611.10 CAD
4/21/202611.12 CAD
4/20/202611.09 CAD
4/17/202611.29 CAD
4/16/202611.30 CAD
4/15/202611.27 CAD
4/14/202611.30 CAD
4/13/202611.15 CAD
4/10/202611.18 CAD
4/9/202611.05 CAD
4/8/202611.06 CAD
4/7/202610.87 CAD
4/6/202610.88 CAD
4/2/202610.74 CAD
3/27/202610.99 CAD
3/26/202611.02 CAD
3/25/202611.10 CAD
3/24/202611.10 CAD
3/23/202610.93 CAD
3/20/202610.84 CAD
3/19/202610.86 CAD
3/18/202610.86 CAD
3/17/202610.93 CAD
3/16/202610.95 CAD
3/13/202610.89 CAD
3/12/202610.85 CAD
3/11/202611.00 CAD
3/10/202610.90 CAD
3/9/202610.77 CAD
3/6/202610.90 CAD
3/5/202610.99 CAD
3/4/202610.95 CAD
2/26/202611.11 CAD
2/25/202611.00 CAD
2/24/202610.99 CAD
2/23/202610.72 CAD
2/20/202610.68 CAD
2/19/202610.64 CAD
2/18/202610.68 CAD
2/17/202610.68 CAD
2/13/202610.54 CAD
2/12/202610.48 CAD
2/11/202610.48 CAD
2/10/202610.41 CAD
2/9/202610.40 CAD
2/6/202610.30 CAD
2/5/202610.32 CAD
2/4/202610.28 CAD
2/3/202610.27 CAD
2/2/202610.20 CAD
1/30/202610.10 CAD
1/29/202610.10 CAD
1/28/202610.16 CAD
1/27/202610.17 CAD
1/26/202610.16 CAD
1/23/202610.24 CAD
1/22/202610.22 CAD
1/21/202610.17 CAD
1/20/202610.18 CAD
1/19/202610.35 CAD
1/16/202610.30 CAD
1/15/202610.21 CAD
1/14/202610.20 CAD
1/13/202610.18 CAD
1/12/202610.20 CAD
1/9/202610.30 CAD
1/8/202610.38 CAD
1/7/202610.21 CAD
1/6/202610.21 CAD
1/5/202610.22 CAD
1/2/202610.22 CAD
12/31/202510.25 CAD
12/30/202510.42 CAD
12/29/202510.49 CAD
12/24/202510.45 CAD
12/23/202510.23 CAD
12/22/202510.24 CAD
12/19/202510.26 CAD
12/18/202510.37 CAD
12/17/202510.43 CAD
12/16/202510.40 CAD
12/15/202510.47 CAD
12/12/202510.42 CAD
12/11/202510.46 CAD
12/10/202510.50 CAD
12/9/202510.44 CAD
12/8/202510.45 CAD
12/5/202510.48 CAD
12/4/202510.50 CAD
12/3/202510.46 CAD
12/2/202510.25 CAD
12/1/202510.26 CAD
11/28/202510.30 CAD
11/27/202510.30 CAD
11/26/202510.40 CAD
11/25/202510.25 CAD
11/24/20259.94 CAD
11/21/202510.00 CAD
11/20/20259.90 CAD
11/19/20259.79 CAD
11/18/20259.52 CAD
11/17/20259.57 CAD
11/14/20259.53 CAD
11/13/20259.50 CAD
11/12/20259.42 CAD
11/11/20259.39 CAD
11/10/20259.35 CAD
11/7/20259.34 CAD
11/6/20259.38 CAD
11/5/20259.36 CAD
11/4/20259.30 CAD
11/3/20259.33 CAD
10/31/20259.43 CAD
10/30/20259.35 CAD
10/29/20259.36 CAD
10/28/20259.48 CAD
10/27/20259.40 CAD
10/24/20259.44 CAD
10/23/20259.40 CAD
10/22/20259.36 CAD
10/21/20259.33 CAD
10/20/20259.36 CAD
10/17/20259.28 CAD
10/16/20259.30 CAD
10/15/20259.36 CAD
10/14/20259.27 CAD
10/10/20259.32 CAD
10/9/20259.13 CAD
10/8/20259.30 CAD
10/7/20259.42 CAD
10/6/20259.43 CAD
10/3/20259.52 CAD
10/2/20259.52 CAD
10/1/20259.60 CAD
9/30/20259.45 CAD
9/28/20259.57 CAD
9/25/20259.68 CAD
9/24/20259.63 CAD
9/23/20259.57 CAD
9/22/20259.50 CAD
9/19/20259.50 CAD
9/18/20259.45 CAD
9/17/20259.45 CAD
9/16/20259.55 CAD
9/15/20259.40 CAD
9/12/20259.43 CAD
9/11/20259.51 CAD
9/10/20259.50 CAD
9/9/20259.54 CAD
9/8/20259.44 CAD
9/5/20259.45 CAD
9/4/20259.59 CAD
9/3/20259.40 CAD
9/2/20259.55 CAD
8/29/20259.48 CAD
8/28/20259.44 CAD
8/27/20259.55 CAD
8/26/20259.40 CAD
8/25/20259.49 CAD
8/22/20259.49 CAD
8/21/20259.63 CAD
8/20/20259.60 CAD
8/19/20259.69 CAD
8/18/20259.60 CAD
8/15/20259.57 CAD
8/14/20259.55 CAD
8/13/20259.50 CAD
8/12/20259.44 CAD
8/11/20259.47 CAD
8/8/20259.46 CAD
8/7/20259.43 CAD
Access this data via the Eulerpool API
Get Free API Key

KP Tissue Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
0.00 CAD
-634,000.00 CAD
-1.95 M CAD
Jan 1, 2021
0.00 CAD
-321,000.00 CAD
1.24 M CAD
Jan 1, 2022
0.00 CAD
-12.55 M CAD
-10.25 M CAD
Jan 1, 2023
0.00 CAD
-1.86 M CAD
-4.94 M CAD
Jan 1, 2024
0.00 CAD
0.00 CAD
2.43 M CAD
Jan 1, 2025
0.00 CAD
0.00 CAD
8.50 M CAD
Jan 1, 2026 (e)
2.25 B CAD
190.69 M CAD
10.16 M CAD
Jan 1, 2027 (e)
2.30 B CAD
0.00 CAD
9.89 M CAD

KP Tissue Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 7, 2026, 8:04 PM
 
REVENUEB CAD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB CAD
EBITM CAD
EBIT MARGIN%
NET INCOMEM CAD
NET INCOME GROWTH%
DIV.CAD
DIV. GROWTH%
SHARESM
201220132014201520162017201820192020202120222023202420252026e2027e
–––-0.03––––––––––2.252.30
––-300.001,550.00–––––––––––2.18
–100.00100.00100.00–100.00––––––––100.00100.00
–––-0.03––––––––––2.252.30
–1.00-2.00-33.00–-3.001.00–––-12.00-1.00––190.00–
–100.00100.00100.00–100.00––––––––8.44–
––-2.00-31.00-1.00-5.00–-6.00-1.001.00-10.00-4.002.008.0010.009.00
–––1,450.00-96.77400.00––-83.33-200.00-1,100.00-60.00-150.00300.0025.00-10.00
–0.760.720.720.720.720.720.720.720.720.720.720.850.720.780.78
––-5.26–––––––––18.06-15.298.33–
8.009.729.729.729.729.729.729.629.729.859.959.969.9910.0110.0110.01
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales KP Tissue generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue KP Tissue retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare KP Tissue's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares KP Tissue has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against KP Tissue's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

KP Tissue stock margins

The KP Tissue margin analysis displays the gross margin, EBIT margin, as well as the profit margin of KP Tissue. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for KP Tissue.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
100.00 %
- %
- %
Jan 1, 2021
100.00 %
- %
- %
Jan 1, 2022
100.00 %
- %
- %
Jan 1, 2023
100.00 %
- %
- %
Jan 1, 2024
100.00 %
0.00 %
- %
Jan 1, 2025
100.00 %
0.00 %
- %
Jan 1, 2026 (e)
100.00 %
8.47 %
0.45 %
Jan 1, 2027 (e)
100.00 %
0.00 %
0.43 %

KP Tissue Stock Revenue, EBIT, Earnings per Share

The KP Tissue earnings per share therefore indicates how much revenue KP Tissue has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
0.00 CAD
-0.07 CAD
-0.20 CAD
Jan 1, 2021
0.00 CAD
-0.03 CAD
0.13 CAD
Jan 1, 2022
0.00 CAD
-1.26 CAD
-1.03 CAD
Jan 1, 2023
0.00 CAD
-0.19 CAD
-0.50 CAD
Jan 1, 2024
0.00 CAD
0.00 CAD
0.24 CAD
Jan 1, 2025
0.00 CAD
0.00 CAD
0.85 CAD
Jan 1, 2026 (e)
225.55 CAD
19.04 CAD
1.02 CAD
Jan 1, 2027 (e)
230.52 CAD
0.00 CAD
0.99 CAD

KP Tissue business model & stock analysis

KP Tissue Inc is a Canadian company that was founded in 2012 and is based in Toronto. The company is involved in the manufacturing and distribution of personal and household paper products. KP Tissue Inc is a joint venture between Kruger Products L.P. and private equity firm BMO Capital Partners. Kruger Products L.P. is a well-known Canadian paper products manufacturer.

KP Tissue SWOT Analysis

Strengths

KP Tissue Inc is a leading company in the tissue industry, with a strong market presence and customer base.

The company operates efficient manufacturing facilities, allowing for cost-effective production and competitive pricing.

KP Tissue has established strong relationships with key suppliers, ensuring a reliable supply chain for its raw materials.

The company's strong financial position allows for investments in research and development, innovation, and future growth opportunities.

Weaknesses

KP Tissue faces intense competition from other established players in the tissue industry, making it challenging to maintain market share.

The company's heavy reliance on pulp and paper as raw materials exposes it to fluctuations in prices and availability.

KP Tissue may lack diversification in its product portfolio, potentially limiting growth opportunities in other sectors.

Opportunities

The increasing global demand for tissue products presents a significant growth opportunity for KP Tissue to expand its market reach.

Emerging markets, such as Asia and Latin America, offer untapped potential for the company to enter and capture market share.

Growing consumer awareness of sustainable and eco-friendly products creates an opportunity for KP Tissue to position itself as a leader in environmentally friendly tissue products.

Threats

Changes in government regulations and environmental policies can impact KP Tissue's operations and increase compliance costs.

Economic downturns and fluctuations in consumer spending can affect the demand for tissue products and, consequently, KP Tissue's sales.

The tissue industry's reliance on single-use disposable products may face challenges from societal shifts towards more sustainable and reusable alternatives.

KP Tissue Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

KP Tissue historical P/E ratio, EBIT multiple, and P/S ratio

KP Tissue annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

KP Tissue shares outstanding

The number of shares of KP Tissue was 10.01 M in 2025. This indicates how many shares KP Tissue is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
9.72 M Stocks
Jan 1, 2021
9.85 M Stocks
Jan 1, 2022
9.95 M Stocks
Jan 1, 2023
9.96 M Stocks
Jan 1, 2024
9.99 M Stocks
Jan 1, 2025
10.01 M Stocks
Jan 1, 2026 (e)
10.01 M Stocks
Jan 1, 2027 (e)
10.01 M Stocks

KP Tissue Dividend History

14 years of dividend payments

YearAnnual DividendYoY ChangePayments
20260.39CADYTD—2×
Mar 31, 20260.18CAD 0.0%1/2
Jun 30, 20260.21CAD↑ 16.7%2/2
20250.72CAD↓ 15.3%4×
Mar 31, 20250.18CAD 0.0%1/4
Jun 30, 20250.18CAD 0.0%2/4
Sep 29, 20250.18CAD 0.0%3/4
Dec 31, 20250.18CAD 0.0%4/4
20240.85CAD↑ 18.1%5×
20230.72CAD 0.0%4×
20220.72CAD 0.0%4×
20210.72CAD 0.0%4×
20200.72CAD 0.0%4×
20190.72CAD 0.0%4×
20180.72CAD 0.0%4×
20170.72CAD 0.0%4×

KP Tissue dividend history and estimates

In 2025, KP Tissue paid a dividend amounting to 0.72 CAD. Dividend means that KP Tissue distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2020
0.72 CAD
0.00 CAD
Jan 1, 2021
0.72 CAD
0.00 CAD
Jan 1, 2022
0.72 CAD
0.00 CAD
Jan 1, 2023
0.72 CAD
0.00 CAD
Jan 1, 2024
0.85 CAD
0.00 CAD
Jan 1, 2025
0.72 CAD
0.00 CAD
Jan 1, 2026 (e)
0.39 CAD
0.39 CAD
Jan 1, 2027 (e)
0.00 CAD
0.78 CAD

KP Tissue dividend payout ratio

In 2025, KP Tissue had a payout ratio of 84.79%. The payout ratio indicates the percentage of the company's profits that KP Tissue distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
-358.38 %
Jan 1, 2021
572.63 %
Jan 1, 2022
-69.86 %
Jan 1, 2023
-145.30 %
Jan 1, 2024
221.64 %
Jan 1, 2025
84.79 %
Jan 1, 2026 (e)
76.59 %
Jan 1, 2027 (e)
78.72 %

Current KP Tissue forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
4.76 %
Buy
0.00 % (0)
Hold
60.00 % (6)
Sell
40.00 % (4)
12M Price Target
11.22
Last Price
12.86
Currency
CAD
12M Return Potential
-12.75 %
LTM Return
0 %

KP Tissue Earnings Calls

2025

KP Tissue Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
5/9/20240.20CAD--CAD-2024 Q1
3/7/20240.21CAD-500.96 MCAD-2023 Q4
8/9/2023-0.09CAD--CAD-2023 Q2
5/10/2023-0.11CAD--CAD-2023 Q1
3/8/2023-0.07CAD-486.08 MCAD-2022 Q4
11/9/2022-0.14CAD-452.44 MCAD-2022 Q3
8/11/2022-0.21CAD-428.63 MCAD-2022 Q2
5/12/2022-0.10CAD-394.78 MCAD-2022 Q1
3/10/2022-0.04CAD-395.19 MCAD-2021 Q4
11/12/20210.05CAD-391.79 MCAD-2021 Q3

EESG©

Eulerpool ESG Scorecard© for the KP Tissue stock

21/100
31
Environment
9
Social
22
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

KP Tissue shareholder structure

% Name
0.76947%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.23383%
Bianco (Dino Joe)
Bianco (Dino Joe)
0.22853%
Dimensional Fund Advisors, Ltd.
Dimensional Fund Advisors, Ltd.
0.19274%
Vimard (Francois)
Vimard (Francois)
0.17363%
Hardy (James Richmond)
Hardy (James Richmond)
0.07838%
DFA Australia Ltd.
DFA Australia Ltd.

KP Tissue Beneficial Ownership Filings (SEC 13D/G)

Free Float
99.3%
Float Shares
-
Shares Outstanding
-

KP Tissue Executives and Management Board

13 members · avg. age 63 · 15 % women

DB

Mr. Dino Bianco (63)

Chief Executive Officer

2.08 M CAD

Management

GG

Mr. Gordon Goss

Senior Vice President, General Manager - Consumer Business, USA and Mexico

1.22 M CAD
RM

Mr. Robert Martin

Senior Vice President - Operations

1.15 M CAD
MM

Mr. Michel Manseau

Senior Vice President, General Manager - Consumer Business, Canada

1.03 M CAD
MK

Mr. Michael Keays

Chief Financial Officer

720,277.00 CAD
JO

Mr. John O'Hara

Senior Vice President, General Counsel - Away from Home

478,234.00 CAD
FP

Mr. Francois Paroyan

Senior Vice President, General Counsel and Corporate Affairs, Corporate Secretary · since 2018

–

Board of Directors

JH

Mr. James Hardy

Independent Director

88,250.00 CAD
FV

Mr. Francois Vimard (62)

Independent Chairman of the Board

86,250.00 CAD
JW

Mr. John Wright

Independent Director

72,500.00 CAD
SK

Ms. Sarah Kruger

Director

–
DG

Mr. Doris Grbic

Director - Investor Relations · since 2024

–

KP Tissue Supply Chain

KP Tissue Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#NameTrend
1
Kimberly-Clark
Supplier·Customer·Household Products·US
-0.07
0.72
0.40
-0.23
-0.26
0.59

Frequently asked questions about KP Tissue

The business model of KP Tissue Inc is focused on manufacturing and distributing a wide range of tissue products. As a leading Canadian consumer product company, KP Tissue Inc specializes in producing and distributing bathroom tissues, paper towels, and facial tissues primarily under the brand name "Cashmere." The company's business model includes a vertically integrated approach, with operations involving the production of finished products, sourcing raw materials, and managing distribution channels. Through strategic partnerships and a commitment to quality, KP Tissue Inc aims to meet the growing demand for tissue products while delivering value to its customers and shareholders.

KP Tissue Inc is primarily active in the tissue industry.

The main competitors of KP Tissue Inc in the market are Cascades Inc and Clearwater Paper Corporation.

KP Tissue Inc is a Canadian company that specializes in the manufacturing and distribution of tissue products. Founded in 2012, KP Tissue Inc has quickly become a prominent player in the industry. The company operates through its subsidiary, Kruger Products L.P., which is a leading manufacturer of tissue and paper products in North America. With a rich history spanning several decades, KP Tissue Inc has built a strong reputation for delivering high-quality and innovative tissue solutions to consumers and businesses. The company's commitment to sustainability and customer satisfaction has contributed to its continued growth and success in the market. KP Tissue Inc continues to be a trusted name in the tissue industry, offering products that meet the needs of a diverse customer base.

KP Tissue Inc has achieved several significant milestones throughout its history. One notable accomplishment is its acquisition of Orchids Paper Products, a leading manufacturer of tissue products, which has expanded the company's market reach and product offerings. Additionally, KP Tissue Inc has successfully established strategic partnerships with key retailers, further enhancing its distribution network and brand visibility. The company has also focused on investing in advanced manufacturing technologies to improve efficiency and product quality. With a strong commitment to innovation and customer satisfaction, KP Tissue Inc continues to make strides in the tissue industry, ensuring its position as a trusted and reliable provider of high-quality tissue products.

KP Tissue Inc is primarily present in Canada and the United States.

KP Tissue Inc represents values of excellence, innovation, and sustainability. The company's corporate philosophy is centered around providing quality products and services to its customers while maintaining a focus on environmental responsibility. KP Tissue Inc strives to be a leader in the tissue industry by continuously improving its processes and leveraging cutting-edge technologies. With a commitment to social and environmental stewardship, the company aims to create long-term value for its stakeholders. KP Tissue Inc's dedication to these values and corporate philosophy sets it apart in the market, making it a trusted and sustainable choice for investors.

Analysts currently set an average price target of 11.22 CAD for the KP Tissue stock (median: 11.22 CAD), implying -12.8 % versus the latest price. The consensus is based on 10 analyst ratings.

KP Tissue Analyst Price Targets 2026

10 analysts currently rate the KP Tissue stock: 0 recommend buying, 6 holding and 4 selling. For 2026, analysts expect KP Tissue to generate revenue of 2.25 B CAD and earnings per share of 1.01 CAD.

KP Tissue Analyst Price Targets 2026

Converted at the current exchange rate, the KP Tissue share trades at 7.96 EUR (12.86 CAD).

The KP Tissue share (KPT.TO) is listed on 2 stock exchanges, including: Toronto (KPT.TO).

KP Tissue Inc. is a leading manufacturer of paper products, specializing in the production of toilet paper, paper towels, and tissues. The company operates three different business segments: Kruger Products L.P., Kruger Products (USA) Inc., and KPLP Finance Co. KP Tissue Inc. is a Canadian company listed on the Toronto Stock Exchange under the symbol KPT. Kruger Products L.P. is one of the largest toilet paper, paper towel, and tissue manufacturers in Canada. The company has been continuously growing since its establishment in 1904 and has a wide range of products sold under various brands, including Cashmere, Purex, SpongeTowels, Scotties, and White Swan. Kruger Products L.P. takes pride in manufacturing all its products from 100% recycled paper, making it one of the most environmentally friendly toilet paper, paper towel, and tissue manufacturers. Kruger Products (USA) Inc. is the American counterpart to Kruger Products L.P. The company is based in Memphis, Tennessee, and specializes in the production of paper products. Kruger Products (USA) Inc. sells its products under various brands, such as White Cloud, Preference, and Jumbo. KPLP Finance Co. is a subsidiary of KP Tissue Inc. and is a pure financial service provider. The company ensures that its subsidiaries have sufficient capital and resources to continue their businesses successfully. The toilet paper, paper towel, and tissue brands of KP Tissue Inc. have an excellent reputation and are highly popular among consumers in Canada and the USA. The company places special emphasis on the quality of its products and has even developed the "Ultimate Use Experience" to allow customers to experience a product in action. The goal is to develop a great product that meets the needs of consumers. All products from KP Tissue Inc. are made from 100% recycled paper, making them environmentally friendly. Overall, the business model of KP Tissue Inc. is very successful, and there is great potential for growth and expansion. The company has earned an excellent reputation in the industry and is on track to solidify its position as a leading manufacturer of paper products in North America.

The expected revenue of KP Tissue is 2.25 B CAD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of KP Tissue is 10.16 M CAD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of KP Tissue is currently 12.68. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the KP Tissue stock.

The price-to-sales ratio (P/S) of KP Tissue is currently 0.06. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the KP Tissue stock.

The Eulerpool Quality Score for KP Tissue is 0/10.

The ISIN of KP Tissue is CA48265Y1043. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of KP Tissue is A1KAN1. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of KP Tissue is KPT.TO. The ticker symbol is used to trade KP Tissue shares on the stock exchange.

Over the past 12 months, KP Tissue paid a dividend of 0.72 CAD . This corresponds to a dividend yield of about 5.60 %. For the coming 12 months, KP Tissue is expected to pay a dividend of 0.78 CAD.

The current dividend yield of KP Tissue is 5.60 %.

KP Tissue pays a dividend, distributed in the months of , , , .

KP Tissue paid dividends every year for the past 13 years.

For the upcoming 12 months, dividends amounting to 0.78 CAD are expected. This corresponds to a dividend yield of 6.07 %.

KP Tissue is assigned to the 'Non-cyclical consumption' sector.

In the year 2025, KP Tissue distributed 0.85 CAD as dividends.

The dividends of KP Tissue are distributed in CAD.

All fundamentals and in-depth analysis of KP Tissue

Our stock analysis for KP Tissue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of KP Tissue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

KP Tissue Stock
KP Tissue Revenue→
KP Tissue Stock
KP Tissue Net Income→
KP Tissue Stock
KP Tissue P/E→
KP Tissue Stock
KP Tissue P/S→
KP Tissue Stock
KP Tissue EBIT→
KP Tissue Stock
KP Tissue Dividend→
KP Tissue Stock
KP Tissue Directors Dealings→
KP Tissue Stock
KP Tissue Stocks→
KP Tissue Stock
KP Tissue Market capitalization→
KP Tissue Stock
KP Tissue Debt→
KP Tissue Stock
KP Tissue Liabilities→
KP Tissue Stock
KP Tissue Equity→
KP Tissue Stock
KP Tissue AAQS→
KP Tissue Stock
KP Tissue Employees→
KP Tissue Stock
KP Tissue ROE→
KP Tissue Stock
KP Tissue ROA→
KP Tissue Stock
KP Tissue ROCE→
KP Tissue Stock
KP Tissue News→
KP Tissue Stock
KP Tissue Analyst Price Targets→

Non-cyclical consumption Stocks

Kraft HeinzKovilpatti Lakshmi Roller Flour MillsKRBLKotobuki Spirits CoKri-Kri Milk IndustryKothari Sugars and ChemicalsKriti NutrientsKothari Fermentation and BiochemKrogerKose HoldingsKrynica VitaminKorea Industrial CoAll Stocks A–Z →